Target intelligence / Profile preview

SARS-CoV-2 nonstructural protein 15 endoribonuclease (Nsp15)

Target
Nsp15
Molecular classification
Enzyme, Endoribonuclease, NendoU family
01

Overview

SARS-CoV-2 nonstructural protein 15 (Nsp15) is a uridylate-specific endoribonuclease (NendoU) that plays a critical role in the viral life cycle by facilitating immune evasion (UniProt P0DTD1). It functions by cleaving poly-uridine sequences at the 5' ends of negative-strand viral RNA, thereby preventing the activation of host pattern recognition receptors such as MDA5, which would otherwise trigger a robust interferon-mediated antiviral response (Hackbart et al., 2020). Structurally, Nsp15 exists as a hexamer, and its catalytic activity is dependent on manganese ions (Kim et al., 2020). Because Nsp15 is highly conserved among coronaviruses and lacks a direct human homolog, it is considered a promising target for the development of broad-spectrum antiviral therapies. Small molecules like Tipiracil and Ebselen have been identified as potential inhibitors that disrupt its enzymatic activity, potentially restoring the host's ability to detect and clear the virus (Zhang et al., 2021).

Other names
Nsp15NendoUUridylate-specific endoribonucleaseNon-structural protein 15Endoribonuclease Nsp15
02

Mechanism of action

Inhibition of the uridylate-specific endoribonuclease activity to prevent viral immune evasion and suppress viral replication.

03

Biological functions

RNA processingImmune evasionViral replicationInhibition of host innate immune response
04

Disease associations

InfectionCOVID-19
05

Safety considerations

Off-target effects on host endoribonucleasesPotential for viral resistance mutationsBioavailability and delivery to infected tissues
06

Interacting drugs

Tipiracil

3 more in the full profile.

07

Biomarkers

SARS-CoV-2 viral loadInterferon-beta levelsPro-inflammatory cytokine levels

Beyond the preview

Go deeper on SARS-CoV-2 nonstructural protein 15 endoribonuclease (Nsp15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARS-CoV-2 nonstructural protein 15 endoribonuclease (Nsp15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call